Mark A Ator Selected Research

Mark A Ator Research Topics

Disease

11	Neoplasms (Cancer) 02/2015 - 12/2003
3	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 03/2012 - 02/2006
2	Schizophrenia (Dementia Praecox) 01/2012 - 11/2010
1	Migraine Disorders (Migraine) 01/2020
1	Basal Cell Carcinoma (Rodent Ulcer) 11/2017
1	Huntington Disease (Huntington's Disease) 10/2016
1	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2016
1	Demyelinating Diseases (Demyelinating Disease) 10/2016
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 10/2016
1	Inflammation (Inflammations) 10/2016
1	Multiple Sclerosis 10/2016
1	Chronic Progressive Multiple Sclerosis 10/2016
1	Sleep Wake Disorders 01/2016
1	Acute Erythroblastic Leukemia (Erythroleukemia) 04/2012
1	Hyperplasia 04/2012
1	Melanoma (Melanoma, Malignant) 04/2012
1	Colorectal Neoplasms (Colorectal Cancer) 04/2012
1	Carcinoma (Carcinomatosis) 04/2012
1	Genetic Translocation (Chromosomal Translocation) 03/2012
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2012
1	Neuroblastoma 03/2012
1	Sarcoma (Soft Tissue Sarcoma) 02/2012
1	Splenomegaly 10/2011
1	Lupus Nephritis 10/2011
1	Cognitive Dysfunction 07/2011
1	Autoimmune Diseases (Autoimmune Disease) 04/2011
1	Arthritis (Polyarthritis) 04/2011
1	Rheumatoid Arthritis 04/2011
1	Body Weight (Weight, Body) 04/2011
1	Multiple Myeloma 02/2008
1	Leukemia 02/2006

Drug/Important Bio-Agent (IBA)

4	Anaplastic Lymphoma KinaseIBA 05/2012 - 02/2006
3	Proteins (Proteins, Gene)FDA Link 04/2012 - 02/2006
2	Tyrosine (L-Tyrosine)FDA Link 06/2012 - 03/2012
2	Chymotrypsin FDA Link 05/2012 - 04/2012
2	Proteasome Endopeptidase Complex (Proteasome)IBA 05/2012 - 04/2012
2	agerafenibIBA 04/2012 - 02/2012
2	Proteasome InhibitorsIBA 04/2012 - 02/2008
2	CytokinesIBA 01/2012 - 04/2011
2	6- (4- (3- (2- methylpyrrolidin- 1- yl)propoxy)phenyl)- 2H- pyridazin- 3- oneIBA 01/2012 - 07/2011
2	CEP 33779IBA 10/2011 - 04/2011
1	oxazine 1IBA 01/2020
1	Calcitonin Gene-Related Peptide Receptor AntagonistsIBA 01/2020
1	piperidineIBA 01/2020
1	Histone Deacetylase 1IBA 11/2017
1	Transcription Factors (Transcription Factor)IBA 11/2017
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 10/2016
1	Myelin-Oligodendrocyte GlycoproteinIBA 10/2016
1	laquinimodIBA 10/2016
1	3- (1'- cyclobutylspiro(4H- 1,3- benzodioxine- 2,4'- piperidine)- 6- yl)- 5,5- dimethyl- 1,4- dihydropyridazin- 6- oneIBA 01/2016
1	AcrylonitrileIBA 02/2015
1	Phosphotransferases (Kinase)IBA 06/2012
1	CrizotinibIBA 05/2012
1	MitogensIBA 04/2012
1	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 04/2012
1	Interferon Regulatory Factor-1 (Interferon Regulatory Factor 1)IBA 04/2012
1	CEP-28122IBA 03/2012
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2012
1	Antipsychotic Agents (Antipsychotics)IBA 01/2012
1	Histamine (Histamine Dihydrochloride)FDA Link 07/2011
1	Janus Kinase InhibitorsIBA 04/2011
1	AutoantibodiesIBA 04/2011
1	CollagenIBA 04/2011
1	Dihydrotachysterol (AT 10)IBA 04/2011
1	InterferonsIBA 04/2011
1	InterleukinsIBA 04/2011
1	Interleukin-12 (IL 12)IBA 04/2011
1	Collagen Type II (Type II Collagen)IBA 04/2011
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 04/2011
1	Janus Kinase 2IBA 04/2011
1	EnzymesIBA 12/2010
1	Insulin ReceptorIBA 12/2010
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 11/2010
1	Glycine Plasma Membrane Transport ProteinsIBA 11/2010
1	N-Methylaspartate (NMDA)IBA 11/2010
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 11/2010
1	Bortezomib (Velcade)FDA Link 02/2008
1	dimethylglycineIBA 12/2003
1	ProdrugsIBA 12/2003
1	EstersIBA 12/2003
1	compound 21IBA 12/2003

Therapy/Procedure

5	Therapeutics 05/2012 - 01/2012
2	Oral Administration 04/2012 - 04/2011